Gorman-Rupp (AMEX: GRC) is expected to report Q2 earnings around July 22. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Gorman-Rupp's revenues will increase 2.0% and EPS will drop -8.3%.
The average estimate for revenue is $94.4 million. On the bottom line, the average EPS estimate is $0.33.
Last quarter, Gorman-Rupp logged revenue of $92.5 million. GAAP reported sales were 10% lower than the prior-year quarter's $102.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.28. GAAP EPS of $0.28 for Q1 were 43% lower than the prior-year quarter's $0.49 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 23.0%, 290 basis points worse than the prior-year quarter. Operating margin was 8.9%, 590 basis points worse than the prior-year quarter. Net margin was 6.3%, 370 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $381.5 million. The average EPS estimate is $1.35.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 291 members out of 304 rating the stock outperform, and 13 members rating it underperform. Among 60 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 58 give Gorman-Rupp a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gorman-Rupp is outperform, with an average price target of $30.67.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Gorman-Rupp to My Watchlist.